Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease. | Life (Basel) | 2022 | 36295058 | PubTator, text mining | PubMed |
| Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation? | Int J Mol Sci | 2022 | 36293117 | PubTator, text mining | PubMed |
| Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses. | Cancers (Basel) | 2022 | 36291782 | PubTator, text mining | PubMed |
| Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. | Nat Immunol | 2022 | 36289449 | PubTator, text mining | PubMed |
| Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis. | JCI Insight | 2022 | 36278483 | PubTator, text mining | PubMed |
| Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates. | Front Immunol | 2022 | 36275702 | PubTator, text mining | PubMed |
| Ageing-Associated Transcriptomic Alterations in Peri-Implantitis Pathology: A Bioinformatic Study. | Dis Markers | 2022 | 36267464 | PubTator, text mining | PubMed |
| Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing. | BJUI Compass | 2022 | 36267207 | PubTator, text mining | PubMed |
| Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes Signature. | Neurol Neuroimmunol Neuroinflamm | 2022 | 36266053 | PubTator, text mining | PubMed |
| Engineering neoantigen vaccines to improve cancer personalized immunotherapy. | Int J Biol Sci | 2022 | 36263174 | PubTator, text mining | PubMed |
| Delineating the transcriptional landscape and clonal diversity of virus-specific CD4+ T cells during chronic viral infection. | Elife | 2022 | 36255051 | PubTator, text mining | PubMed |
| Analysis of differentially expressed genes in individuals with noninfectious uveitis based on data in the gene expression omnibus database. | Medicine (Baltimore) | 2022 | 36254061 | PubTator, text mining | PubMed |
| Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation. | Antiviral Res | 2022 | 36252824 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma. | Clin Transl Med | 2022 | 36245253 | PubTator, text mining | PubMed |
| COVID-19 induces gastrointestinal symptoms and affects patients' prognosis. | J Int Med Res | 2022 | 36238995 | PubTator, text mining | PubMed |
| CD8+ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease. | Int J Mol Sci | 2022 | 36232733 | PubTator, text mining | PubMed |
| Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19. | Cells | 2022 | 36230912 | PubTator, text mining | PubMed |
| Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. | Nat Commun | 2022 | 36229464 | PubTator, text mining | PubMed |
| PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer. | Cancer Res | 2022 | 36222718 | PubTator, text mining | PubMed |
| Evolution and modulation of antigen-specific T cell responses in melanoma patients. | Nat Commun | 2022 | 36220826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=52